Get started
CURALEAF HOLDINGS INCCURALEAF HOLDINGS INCCURALEAF HOLDINGS INC

CURALEAF HOLDINGS INC

No trades
See on Supercharts
Overview Financials News
Ideas
Discussions Technicals Forecast Seasonals Bonds

CURA trade ideas

Curaleaf: Target Zone in SightIn small steps, the CURA stock continues to move upward – however, we primarily interpret these movements as the internal structure of the downward wave v in orange. Therefore, the final low of this wave should soon be marked within the orange Long Target Zone between C$0.82 and C$0.37. Upon completion of wave v, the overarching wave II in beige should also end. Once this foundation is laid, a long-term upward movement should begin – initially driven by wave 1 in turquoise, which should carry the price above the resistance at C$4.93.
NEO:CURA
by MarketIntel
RiskMastery's Breakout Stocks - CURLF EditionWelcome to RiskMastery's Breakout Stocks - Stocks with breakout potential. In this edition, we'll be looking at OTC:CURLF ... I believe this code is at a point of potential volatility. If price can hold above $5.10 ... Bullish potential may be unlocked. My key upside targets include: - $5.86 (Conservative) - $7.06 (Medium) - $8.34 (Aggressive) If however price falls below $4.06 ... Bearish risk potential may be unlocked. (My key risk targets - C, M,& A - are as noted on the chart) Enjoy, and I look forward to being of further service into the future. If you'd like to connect, feel free to reach out and comment below. Mr RM | Risk Mastery Disclaimer: This post is intended for educational purposes only - Publicly available RiskMastery information & content is not intended to be financial advice in any shape or form. Please do your own research and seek advice from a licensed professional before acting on any of the information contained within this post. This post is not a solicitation or recommendation to buy, sell or hold any positions in any financial instrument. All demonstrated trades are merely incidental to the educational training RiskMastery aims to provide. You are solely responsible for your own investment and trading decisions, of which should be made only according to your own opinion, knowledge and experience. You should not rely on any of the information contained on this site or contained in any RiskMastery material on any website or platform. You assume the sole risk of any trade or investment you elect to make. RiskMastery and affiliates shall not be liable to you for any monetary losses or any other damages incurred directly or indirectly, from your use, reliance or reference of RiskMastery materials, content and educational information. Thank you for your understanding and cooperation - We look forward to working with you into the future to navigate the fine line of trading and investment success.
OTC:CURLFLong
by Bullfinder-official
$CURLF Banking On Rippling Cannabis Potential Weed stocks are gaining traction as the industry’s outlook appears to be brighter than ever after the HHS sent a letter to the DEA recommending the rescheduling of marijuana to a Schedule 3 drug. As the largest multistate operator in the US, Curaleaf Holdings, Inc. (OTC: CURLF) may be poised to gain the most from this improved environment which makes its stock a prime candidate to soar over the coming months. That said, the HHS’ recommendation may be a sign that the SAFE Banking Act may pass the Senate vote expected to occur this fall. For these reasons, going long on CURLF stock may provide investors with substantial gains in the long term. CURLF Fundamentals Weed is once again in the spotlight thanks to the HHS’ recent efforts to reschedule the substance. The Biden Administration has been working with the HHS to re-evaluate marijuana’s legal standing. As is, the results of this re-evaluation could be a re-scheduling or de-scheduling which entails total legality. Having said that according to a letter obtained by Bloomberg, the HHS’s findings led to advising the DEA to reschedule Marijuana from a Schedule 1 to a Schedule 3 substance. This outcome may at first seem far-fetched given the FDA’s renowned antagonism regarding drugs, however, the HHS’ recommendation is more in line with the law than most realize. Currently, weed is a Schedule 1 substance which means that it is considered to have a high likelihood of abuse and no medical application. This classification does not reflect reality since marijuana has a lot of medical applications from treating chronic pain to Parkinson’s. It also has a low abuse rate since only 9% of cannabis users suffer from marijuana addiction. If the DEA follows the HHS’ recommendation and re-schedule marijuana, this move will likely create regulatory and political ripples. From a regulatory standpoint, federal institutions will be able to conduct medical research using marijuana which could lead to new treatments. Furthermore, if marijuana is rescheduled into a Schedule 3 drug, the U.S. code IRC 280E will no longer apply to marijuana businesses. IRC 280E basically dictates that any company that trades or does any business with substances in Schedule 1 or 2 is not eligible for tax deductions. This means that if marijuana is rescheduled to schedule III as per the letter obtained by Bloomberg, multistate operators will no longer be subjected to extremely high taxation on a regular basis due to access to tax deductions. From a political standpoint, this move is likely to increase the public’s awareness of the SAFE Banking Act which positively affects marijuana businesses. This will put pressure on politicians, especially since most of their constituency favors weed legalization and elections are right around the corner. As is, 68% of Republican voters and 80% of Democratic voters are pro-cannabis legalization, and overall, 88% of US adults are in favor of legalization. This means that US politicians, regardless of Party affiliation, will likely feel pressured to vote in favor of the Act which is expected to be this fall. If this bill passes, marijuana businesses will have access to the financial system, meaning that they will be able to store their money in banks and take out loans instead of relying on cash. In light of this, CURLF stock could be considered a noteworthy long-term investment since it is currently operating in 20 states making it the largest US cannabis producer and distributor. CURLF Financials According to the company’s Q2 2023 report, its assets slightly decreased from $3.4 billion at the beginning of the year to $3.3 billion as a result of the company’s cash balance decreasing from $163.1 million to $85 million due to the cash used in financing activities from continuing operations. On the other hand, liabilities remained relatively unchanged only decreasing from $2 billion to $1.9 billion. When it comes to revenue the company experienced a YoY increase from $326.9 million to $338.5 million. This occurred thanks to retail and wholesale revenue increasing from $325.7 million to $337 million. Meanwhile, total operating expenses increased from $143.9 million to $153.6 million. That said, the company recorded a significant income tax expense that amounted to $41.3 million and increased its cost of revenue from $147.9 million to $192 million. However, this increase in cost of revenue is normal given the company’s extensive endeavors while its taxes may decrease significantly if marijuana is re-scheduled to a Schedule 3 substance. Given these factors, the company’s net loss increased from $21.7 million to $74.4 million. Technical Analysis CURLF Stock recently exited a bearish trend as it was trading in a downward channel. Looking at the indicators, the stock is trading above the 200, 50, and 21 MAs which is a bullish sign. Meanwhile, the RSI is overbought at 70 and the MACD is bullish to the upside. As for the fundamentals, CURLF has the largest footprint out of all multistate operators with operations in 20 states. For this reason, the company may benefit the most from the growing momentum toward marijuana re-scheduling and the potential passage of the SAFE Banking Act. With the stock yet to confirm breaking its downward channel, investors could wait for the stock to retest the upper trend line and go long ahead of the SAFE Banking Act vote that is expected to occur this fall. CURLF Forecast Given the HHS’ recent re-scheduling recommendation regarding cannabis, the marijuana industry may be poised to experience significant benefits. If cannabis is rescheduled into a Schedule 3 substance by the DEA, multi-state operators will be taxed at much better terms as they would be eligible for tax deductions. Meanwhile, the HHS’ recommendation likely means that the SAFE Banking Act may very likely pass the Senate vote expected to take place this fall. Given the potential of this news on the marijuana industry, going long on CURLF stock may prove to be a profitable long-term investment given its status as the largest multistate operator in the US.
OTC:CURLF
by Penny_Stocks_Today
Curaleaf Holdings Corp. - $CURLF Chart AnalysisTAKE A HIT OR LET IT SIT? ​ Curaleaf ($CURLF) I would expect to see this the next few weeks to form some kind of flat running/triangle pattern or could be the perfect storm to just drop the price even more. We are currently entering a high traffic zone due to all the prior waves coming hot as they enter their respectful 3rd-4th waves to their final stretch of the 5th. I expect to see some MACD divergence to start displaying on the indicator, signaling the correction and confirming the leg onto the 5th wave. PT $4.62 - $4.11 (with hardly any support underneath, I would expect for selling or some hard flash sales/knives). Since I made the market prediction (Mar. 10th/Twitter post), it's been over 1 month and the stock price seems to behave identical towards my technical analysis. *Bonus Possibility I feel like we'll see some slight movement down to $6 end of April and could see a fast reaction or this will play out as long extension that lasts well into August. The $4.20(ish) stock price movement for the August sell of still stands, but I think we will see this ticker get smoked on a little more and burn this join to the ashes. ​I feel the mid May will have a sell off that will rally some investors to buy more only to have the rug pulled underneath them by August, which will be a good sign for everyone else to start selling as I feel the rest of the year is done for Curleaf and will set a new alert around $3.50 for the end of the year.
OTC:CURLF
by happytree614
CURLF: Valuation Consolidation CURLF is a solid MJ company but might need to consolidate on valuation basis - Head and Shoulders are forming and could prove to be a good catalyst for such an event - Elements of break down are visible: volume is deteriorating (into head and right shoulder), trend is diverging, relative performance is weak - Longer term view remains constructive and many positive catalysts exist for MJ hence some breakdown is needed before entering a position
OTC:CURLFShort
by quantitativetendies
$CURLF Curaleaf Holdings Targets Curaleaf Holdings , Inc. is a life science company, which engages in owning and managing licensed cannabis businesses which cultivate, process and/or dispense cannabis and cannabis derived products. It operates through Cannabis Operations and Non-Cannabis Operations segments. The Cannabis Operations segment production and sale of cannabis via retail and wholesale channels. The Non-Cannabis Operations segment provides professional services including cultivation, processing and retail know-how, and back office administration, intellectual property licensing,real estate leasing services, and lending facilities to medical and adult-use cannabis licensee. The company was founded on November 13, 2014 and is headquartered in Vancouver, Canada.
OTC:CURLFLong
by OTCMarketsExpert
CURLF Descending Broadening Wedge| Volume Influx| Technical HighEvening Traders, Today’s Analysis – Curaleaf Holdings, Inc. – as swing trade into technical target as US voting season approaches. - Macro broadening wedge - Dynamic Resistance broken - 200 MA support - RSI bearish divergence - Volume influx - Back test long CURLF has broken bullish from its macro descending wedge, initiating the pattern with a clear technical target. The break has put in a valid higher high, first sign of a probable trend change. The Dynamic resistance was broken with conviction; a back test will be in confluence with the 21 MA and the .618 Fibonacci. This will allow for a risk defined long entry The 200 MA is holding as support, price will remain bullish as long as it trades above. The RSI has a valid bearish divergence; this indicates a correction being probable to the .618, a clear trade location with technical confluences. There is a clear volume influx coinciding with the break of the pattern, follow through is required for continuation. Overall, in my opinion, CURLF has validated its macro pattern; a back test is a valid long entry with defined risk. On a fundamentally scale, this sector will be approaching voting, speculators are likely to be positon themselves for macro swings. What are your thoughts? “Win, loss whatever emerges in the short-term, place and manage your next trades untouched, unattached... always keeping your eyes on the long-term picture.” ― Yvan Byeajee
OTC:CURLFLong
by The_Alchemist_Trader_
5